Name | Number of supported studies | Average coverage | |
---|---|---|---|
B cell | 17 studies | 24% ± 9% | |
naive B cell | 15 studies | 26% ± 6% | |
plasma cell | 13 studies | 31% ± 13% | |
oligodendrocyte | 12 studies | 39% ± 10% | |
astrocyte | 11 studies | 30% ± 13% | |
oligodendrocyte precursor cell | 7 studies | 25% ± 8% | |
GABAergic neuron | 6 studies | 43% ± 19% | |
endothelial cell | 5 studies | 26% ± 9% | |
memory B cell | 5 studies | 21% ± 4% | |
glutamatergic neuron | 4 studies | 52% ± 22% | |
immature B cell | 4 studies | 27% ± 7% | |
IgA plasma cell | 4 studies | 28% ± 14% | |
interneuron | 4 studies | 36% ± 16% | |
precursor B cell | 3 studies | 19% ± 3% | |
germinal center B cell | 3 studies | 26% ± 9% | |
plasmablast | 3 studies | 34% ± 8% | |
IgG plasma cell | 3 studies | 25% ± 8% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 10 studies | 34% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 2505.77 | 2642 / 2642 | 100% | 19.90 | 705 / 705 |
breast | 100% | 2020.06 | 459 / 459 | 97% | 26.15 | 1089 / 1118 |
prostate | 99% | 1230.27 | 243 / 245 | 97% | 8.45 | 487 / 502 |
adrenal gland | 100% | 2701.41 | 258 / 258 | 96% | 7.49 | 220 / 230 |
thymus | 100% | 1152.71 | 652 / 653 | 91% | 6.69 | 551 / 605 |
esophagus | 97% | 1259.76 | 1408 / 1445 | 93% | 5.73 | 170 / 183 |
lung | 99% | 1113.50 | 573 / 578 | 91% | 5.42 | 1048 / 1155 |
stomach | 95% | 829.99 | 341 / 359 | 84% | 4.46 | 241 / 286 |
skin | 100% | 1659.57 | 1807 / 1809 | 77% | 4.04 | 363 / 472 |
intestine | 100% | 1774.14 | 965 / 966 | 72% | 3.30 | 378 / 527 |
uterus | 100% | 1566.92 | 170 / 170 | 57% | 2.42 | 263 / 459 |
bladder | 100% | 1557.86 | 21 / 21 | 57% | 2.63 | 285 / 504 |
ovary | 100% | 1322.31 | 180 / 180 | 49% | 1.58 | 210 / 430 |
kidney | 71% | 373.04 | 63 / 89 | 74% | 3.40 | 669 / 901 |
liver | 87% | 415.15 | 196 / 226 | 41% | 1.46 | 166 / 406 |
pancreas | 50% | 219.89 | 165 / 328 | 68% | 2.86 | 121 / 178 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.38 | 29 / 29 |
spleen | 100% | 1340.46 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1408.91 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1915.57 | 801 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 1696.07 | 1201 / 1204 | 0% | 0 | 0 / 0 |
heart | 96% | 959.28 | 826 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 73% | 3.58 | 33 / 45 |
peripheral blood | 44% | 1113.81 | 406 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 28% | 0.76 | 22 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0016192 | Biological process | vesicle-mediated transport |
GO_0007030 | Biological process | Golgi organization |
GO_0032482 | Biological process | Rab protein signal transduction |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005802 | Cellular component | trans-Golgi network |
GO_0005795 | Cellular component | Golgi stack |
GO_0000139 | Cellular component | Golgi membrane |
GO_0005801 | Cellular component | cis-Golgi network |
GO_0031985 | Cellular component | Golgi cisterna |
GO_0005525 | Molecular function | GTP binding |
GO_0005515 | Molecular function | protein binding |
GO_0003924 | Molecular function | GTPase activity |
Gene name | RAB30 |
Protein name | Ras-related protein Rab-30 RAB30, member RAS oncogene family, isoform CRA_a (cDNA FLJ78283, highly similar to Homo sapiens RAB30, member RAS oncogene family (RAB30), mRNA) (cDNA, FLJ92634, Homo sapiens RAB30, member RAS oncogene family (RAB30), mRNA) RAB30, member RAS oncogene family |
Synonyms | hCG_27287 |
Description | FUNCTION: The small GTPases Rab are key regulators of intracellular membrane trafficking, from the formation of transport vesicles to their fusion with membranes. Rabs cycle between an inactive GDP-bound form and an active GTP-bound form that is able to recruit to membranes different set of downstream effectors directly responsible for vesicle formation, movement, tethering and fusion (By similarity). Required for maintaining the structural integrity of the Golgi apparatus, possibly by mediating interactions with cytoplasmic scaffolding proteins. . |
Accessions | E9PRX0 E9PS06 ENST00000534301.5 ENST00000528379.1 E9PLM3 ENST00000526205.5 H0YDK7 ENST00000525117.5 E9PQ07 A8K5R1 ENST00000531021.5 ENST00000534141.5 [Q15771-2] ENST00000260056.6 [Q15771-1] ENST00000533486.5 [Q15771-1] E9PPW9 E9PRF7 ENST00000534103.5 ENST00000612684.4 [Q15771-1] E9PMJ1 Q15771 E9PNB9 ENST00000530224.5 ENST00000533014.5 E9PI18 ENST00000533276.6 ENST00000524635.1 ENST00000527633.6 [Q15771-1] ENST00000532548.5 E9PJQ5 |